Recent News and Discussions About Frequency Therapeutics Layoffs
Sensorion sinks as lead hearing loss program flounders in …
https://www.fiercebiotech.com/biotech/sensorion-fails-midstage-sudden-hearing-loss-study-but-awaits-more-data-march-before
Jan 19, 2022 — RELATED: Frequency Therapeutics regroups as hearing loss med falls short … Fierce Biotech Layoff Tracker: CytomX slashes workforce by 40%; …
Press Release – Investor Relations – Frequency Therapeutics
https://investors.frequencytx.com/news-releases/news-release-details/frequency-therapeutics-provides-business-updates-and-reports-6
Mar 16, 2022 — Press Release. Frequency Therapeutics Provides Business Updates and Reports Fourth Quarter and Full Year 2021 Financial Results.
Hearing loss specialists at Frequency pin the blame for PhIIa …
When Frequency Therapeutics scored $80 million in cash from Astellas to jumpstart an alliance, the biotech cautiously pointed to Phase I/II data bolstering …
Frequency Therapeutics redesigns study after … – TechCrunch
Nov 9, 2021 — Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs.
Akebia reveals sweeping layoffs and vadadustat partial …
https://www.fiercepharma.com/pharma/akebia-tightening-belt-after-fdas-vadadustat-snub-reveals-sweeping-staff-cuts-and-partial
After safety concerns derailed an approval of Akebia Therapeutics ‘ blockbuster hopeful vadadustat late last month, the company warned that a restructuring …
Frequency Therapeutics Wins Suit Over Adverse Medical …
https://news.bloomberglaw.com/pharma-and-life-sciences/frequency-therapeutics-wins-suit-over-adverse-medical-study-news
Jun 22, 2022 — Company stock plummeted after news about hearing study · Investors said the CEO tried to block them from selling shares.
New data suggests Frequency Therapeutics’ drug regenerates …
https://seekingalpha.com/news/3742156-new-data-suggests-frequency-therapeutics-drug-regenerates-hearing
Sep 22, 2021 — Data from additional subjects in an open-label study found that Frequency Therapeutics ‘ FX-322 led to hearing improvements eight to 12 …
Decibel Therapeutics Strikes a Balance, Adding Regenerative …
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
Jan 29, 2020 — That’s a different approach than the regenerative medicine technology being developed by Frequency Therapeutics (NASDAQ: FREQ).
Hearing loss biotech Decibel makes a lackluster public debut
https://www.bostonglobe.com/2021/02/12/business/hearing-loss-biotech-decibel-raises-127m-public-offering/
Feb 12, 2021 — Decibel is among several biotechs working on cutting-edge therapies for hearing loss. Its rivals include Frequency Therapeutics of Woburn, which …
Biogen faces investors at JP Morgan healthcare conference …
https://www.bizjournals.com/boston/news/2022/01/06/stakes-are-high-as-biogen-faces-investors-next-wee.html
Jan 6, 2022 — (When asked about layoffs by the Business Journal, … Magenta Therapeutics; Frequency Therapeutics ; Fulcrum Therapeutics …